A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis.

MLA

Fujiwara, Naoto, et al. “A Blood-Based Prognostic Liver Secretome Signature Predicts Long-Term Risk of Hepatic Decompensation in Cirrhosis.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 20, no. 5, May 2022, pp. e1188–91. EBSCOhost, https://doi.org/10.1016/j.cgh.2021.03.019.

APA

Fujiwara, N., Fobar, A. J., Raman, I., Li, Q.-Z., Marrero, J. A., Parikh, N. D., Singal, A. G., & Hoshida, Y. (2022). A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 20(5), e1188–e1191. https://doi.org/10.1016/j.cgh.2021.03.019

Chicago

Fujiwara, Naoto, Austin J Fobar, Indu Raman, Quan-Zhen Li, Jorge A Marrero, Neehar D Parikh, Amit G Singal, and Yujin Hoshida. 2022. “A Blood-Based Prognostic Liver Secretome Signature Predicts Long-Term Risk of Hepatic Decompensation in Cirrhosis.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 20 (5): e1188–91. doi:10.1016/j.cgh.2021.03.019.